These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

48 related items for PubMed ID: 9790934

  • 1. Homologue scanning mutagenesis of heregulin reveals receptor specific binding epitopes.
    Harris A, Adler M, Brink J, Lin R, Foehr M, Ferrer M, Langton-Webster BC, Harkins RN, Thompson SA.
    Biochem Biophys Res Commun; 1998 Oct 09; 251(1):220-4. PubMed ID: 9790934
    [Abstract] [Full Text] [Related]

  • 2. High-resolution solution structure of the EGF-like domain of heregulin-alpha.
    Jacobsen NE, Abadi N, Sliwkowski MX, Reilly D, Skelton NJ, Fairbrother WJ.
    Biochemistry; 1996 Mar 19; 35(11):3402-17. PubMed ID: 8639490
    [Abstract] [Full Text] [Related]

  • 3. Mapping a heparin binding site on ErbB-3 epidermal growth factor receptor.
    Adar R, Yayon A.
    Biochem Biophys Res Commun; 2001 Apr 27; 283(1):1-5. PubMed ID: 11322758
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB, Hynes NE, Lane HA.
    Cancer Res; 2002 Jun 01; 62(11):3151-8. PubMed ID: 12036928
    [Abstract] [Full Text] [Related]

  • 5. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase.
    Harari D, Tzahar E, Romano J, Shelly M, Pierce JH, Andrews GC, Yarden Y.
    Oncogene; 1999 Apr 29; 18(17):2681-9. PubMed ID: 10348342
    [Abstract] [Full Text] [Related]

  • 6. Molecular cloning, tissue-specific expression, and chromosomal localization of a novel nerve growth factor-regulated G-protein- coupled receptor, nrg-1.
    Glickman M, Malek RL, Kwitek-Black AE, Jacob HJ, Lee NH.
    Mol Cell Neurosci; 1999 Aug 29; 14(2):141-52. PubMed ID: 10532805
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG, Hosick HL, Ethier SP.
    J Cell Physiol; 2000 Jun 29; 183(3):301-13. PubMed ID: 10797304
    [Abstract] [Full Text] [Related]

  • 11. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
    Wiesmann C, Ultsch MH, Bass SH, de Vos AM.
    Nature; 1999 Sep 09; 401(6749):184-8. PubMed ID: 10490030
    [Abstract] [Full Text] [Related]

  • 12. The EGF receptor binding of recombinant heregulinbeta1/EGF hybrids is blocked by heregulin residue glutamate 195.
    Chau BN, Nandagopal K, Niyogi SK, Campion SR.
    Biochem Biophys Res Commun; 1996 Dec 24; 229(3):882-6. PubMed ID: 8954988
    [Abstract] [Full Text] [Related]

  • 13. Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC.
    Ultsch MH, Wiesmann C, Simmons LC, Henrich J, Yang M, Reilly D, Bass SH, de Vos AM.
    J Mol Biol; 1999 Jul 02; 290(1):149-59. PubMed ID: 10388563
    [Abstract] [Full Text] [Related]

  • 14. Replacement of N-terminal portions of TGF-alpha with corresponding heregulin sequences affects ligand-induced receptor signaling and intoxication of tumor cells by chimeric growth-factor toxins.
    Schmidt M, Wels W.
    Int J Cancer; 2002 Jan 20; 97(3):349-56. PubMed ID: 11774287
    [Abstract] [Full Text] [Related]

  • 15. Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus.
    Tuffereau C, Bénéjean J, Blondel D, Kieffer B, Flamand A.
    EMBO J; 1998 Dec 15; 17(24):7250-9. PubMed ID: 9857182
    [Abstract] [Full Text] [Related]

  • 16. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
    Grant SL, Hammacher A, Douglas AM, Goss GA, Mansfield RK, Heath JK, Begley CG.
    Oncogene; 2002 Jan 17; 21(3):460-74. PubMed ID: 11821958
    [Abstract] [Full Text] [Related]

  • 17. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
    Xu FJ, Stack S, Boyer C, O'Briant K, Whitaker R, Mills GB, Yu YH, Bast RC.
    Clin Cancer Res; 1997 Sep 17; 3(9):1629-34. PubMed ID: 9815853
    [Abstract] [Full Text] [Related]

  • 18. The chemical synthesis and binding affinity to the EGF receptor of the EGF-like domain of heparin-binding EGF-like growth factor (HB-EGF).
    Shin SY, Yokoyama T, Takenouchi T, Munekata E.
    J Pept Sci; 2003 Apr 17; 9(4):244-50. PubMed ID: 12725245
    [Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
    Wingens M, Jacobs-Oomen S, van der Woning SP, Stortelers C, van Zoelen EJ.
    Biochemistry; 2006 Apr 11; 45(14):4703-10. PubMed ID: 16584205
    [Abstract] [Full Text] [Related]

  • 20. Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display.
    Stortelers C, Souriau C, van Liempt E, van de Poll ML, van Zoelen EJ.
    Biochemistry; 2002 Jul 09; 41(27):8732-41. PubMed ID: 12093292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.